Lemsip Chesty Cough

Guaifenesin, the active ingredient in Lemsip Chesty Cough, is an expectorant presented as an oral formulation for oral use. It helps loosen and clear mucus from the respiratory tract, aiding relief of chesty coughs in adults and children. GNH USA supplies Lemsip Chesty Cough as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide.

Lemsip Chesty Cough contains guaifenesin, an expectorant that acts on the respiratory tract to improve mucus clearance. - Chesty cough: loosens thick secretions to facilitate productive coughing. - Mucus clearance: reduces viscosity of airway secretions for easier expectoration. - Cough associated with colds: helps clear mucus, easing cough discomfort.

Guaifenesin is generally well tolerated, but some users may experience adverse reactions.

Common Side Effects: - Nausea: mild stomach upset may occur. - Vomiting: occasional emesis reported. - Dizziness: transient light‑headedness. - Headache: mild to moderate headache. - Gastrointestinal discomfort: abdominal cramping or discomfort. - Rash: mild skin irritation.

Serious or Rare Side Effects: - Allergic reaction: hives, swelling, or anaphylaxis. - Severe rash: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Bronchospasm: difficulty breathing in susceptible individuals. - Hematuria: rare blood in urine. - Angioedema: swelling of face, lips, or tongue.

When using Lemsip Chesty Cough, consider the following precautions. - Pregnancy: consult a healthcare professional before use. - Breastfeeding: discuss potential risks with a doctor. - Renal impairment: use with caution and monitor kidney function. - Known hypersensitivity: avoid if allergic to guaifenesin or formulation components. - Concomitant medications: review all current drugs with a pharmacist. - Store at room temperature below 25°C: keep in the original pack, protect from moisture.

Guaifenesin may interact with other medicines; monitor for combined effects.

Major Interactions (Avoid): - Cough suppressants containing dextromethorphan: may counteract expectorant action. - MAO inhibitors: increased risk of hypertensive reactions when combined with certain decongestants.

Moderate Interactions (Monitor Closely): - Antihistamines: may enhance sedation. - Beta‑agonists: potential additive cardiovascular effects. - Diuretics: may increase risk of electrolyte imbalance.